NET LOSS PER SHARE

3 Months Ended

Mar. 31, 2023

Basic and diluted net loss per share attributable to common stockholders are calculated as follows (in thousands, except share and per share amounts):


	Three Months Ended March 31,
	2023		2022
Net loss attributable to common stockholders, basic	$	(779,528)	$	(81,286)
Change in fair value of dilutive warrants	—		(523,330)
Net loss attributable to common stockholders, diluted	$	(779,528)	$	(604,616)

Weighted-average shares outstanding, basic	1,831,725,009		1,654,322,379
Private Placement Warrants using the treasury stock method	—		27,223,480
Weighted-average shares outstanding, diluted	1,831,725,009		1,681,545,859

Net loss per share:
Basic	$	(0.43)	$	(0.05)
Diluted	$	(0.43)	$	(0.36)

The following outstanding shares of potentially dilutive securities were excluded from the computation of diluted net loss per share attributable to common stockholders because including them would have had an anti-dilutive effect:


	March 31,
Excluded Securities	2023	2022
Private Placement Warrants to purchase common stock	44,350,000	—
Options outstanding to purchase common stock	36,450,296	50,700,238
RSUs outstanding	44,064,453	34,235,618
Employee stock purchase plan	10,251,959	—
If-converted common shares from convertible note	36,737,785	36,737,785
Total	171,854,493	121,673,641

The 2,090,140 shares of common stock equivalents subject to RSUs are excluded from the anti-dilutive table above as the underlying shares remain contingently issuable since the market conditions have not been satisfied as of March 31, 2023 and 2022.